Share:
Peer-Reviewed Publication
Clin Transl Sci2021;14(4):1578-1589.July 1, 2021Journal Article

Diagnostic and prognostic capabilities of a biomarker and EMR-based machine learning algorithm for sepsis.

Ishan Taneja1, Gregory L Damhorst1,2, Carlos Lopez-Espina1, Sihai Dave Zhao3, Ruoqing Zhu3, Shah Khan1, Karen White4, James Kumar4, Andrew Vincent5, Leon Yeh5, Shirin Majdizadeh4, William Weir4, Scott Isbell6, James Skinner4, Manubolo Devanand4, Syed Azharuddin4, Rajamurugan Meenakshisundaram4, Riddhi Upadhyay4, Anwaruddin Syed5, Thomas Bauman5, Joseph Devito5, Charles Heinzmann5, Gregory Podolej5, Lanxin Shen1, Sanjay Sharma Timilsina1, Lucas Quinlan1, Setareh Manafirasi1, Enrique Valera7, Bobby Reddy1,7, Rashid Bashir7
1Prenosis Inc., Chicago, Illinois, USA.
2Department of Medicine, Emory University, Atlanta, Georgia, USA.
3Department of Statistics, University of Illinois at Urbana-Champaign, Champaign, Illinois, USA.
4Biomedical Research Center, Carle Foundation Hospital, Urbana, Illinois, USA.
5OSF Saint Francis Medical Center, Peoria, Illinois, USA.
6Department of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
7Department of Bioengineering, University of Illinois at Urbana-Champaign, Champaign, Illinois, USA.

Abstract

Sepsis is a major cause of mortality among hospitalized patients worldwide. Shorter time to administration of broad-spectrum antibiotics is associated with improved outcomes, but early recognition of sepsis remains a major challenge. In a two-center cohort study with prospective sample collection from 1400 adult patients in emergency departments suspected of sepsis, we sought to determine the diag…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.